Greece Extends international travel Covid-directive until the beginning of April
Greece’s Civil Aviation Authority has extended the current air directive (notam) for international travellers citing reasons for limiting the spread of the coronavirus.
According to the new declaration issued on Sunday, the current measures will be extended until Monday, April 4, 2022.
The extension provides, among others, measures such as the requirement of a Covid-test upon arrival or not depending of the departure country and European Digital Certificates.
https://www.google.com/amp/s/greekcitytimes.c...-of-april/
Looks like Greece is taking COVID-19 seriously, still.
We believe we can produce in the tens of millions of treatment courses of Tollovir in 2022 to meet the demand for drug-grade 3CL protease inhibitors. We will be working with our European partners T-Cell Protect Hellas S. A. to gain Emergency Use Authorization (EUA) in Greece, and of course 3CL Sciences itself, as an Israel-based company, will be looking to advance EUA in Israel. We also expect we could receive EUA in other jurisdictions depending on the need in those jurisdictions.....
https://investor.todosmedical.com/news-events...areholders
"Mr. Meiselbach will focus on liaising with governments regarding the deployment of Tollovir™, Tollovid® and Videssa®.
Mr. Meiselbach was Director for International Affairs at the Biotechnology Innovation Organization (BIO) for five years. In his role, he managed BIO’s international government affairs portfolio for Asia Pacific and worked with BIO’s members to craft international engagement strategies to promote member companies’ business interests abroad...
Greg will lead the effort to align and formalize our interactions with governments in need of our products.”
https://investor.todosmedical.com/news-events...esident-of
Back in Nov. 21
Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece
https://investor.todosmedical.com/news-events...bottles-of
Greece’s Civil Aviation Authority has extended the current air directive (notam) for international travellers citing reasons for limiting the spread of the coronavirus.
According to the new declaration issued on Sunday, the current measures will be extended until Monday, April 4, 2022.
The extension provides, among others, measures such as the requirement of a Covid-test upon arrival or not depending of the departure country and European Digital Certificates.
https://www.google.com/amp/s/greekcitytimes.c...-of-april/
Looks like Greece is taking COVID-19 seriously, still.
We believe we can produce in the tens of millions of treatment courses of Tollovir in 2022 to meet the demand for drug-grade 3CL protease inhibitors. We will be working with our European partners T-Cell Protect Hellas S. A. to gain Emergency Use Authorization (EUA) in Greece, and of course 3CL Sciences itself, as an Israel-based company, will be looking to advance EUA in Israel. We also expect we could receive EUA in other jurisdictions depending on the need in those jurisdictions.....
https://investor.todosmedical.com/news-events...areholders
"Mr. Meiselbach will focus on liaising with governments regarding the deployment of Tollovir™, Tollovid® and Videssa®.
Mr. Meiselbach was Director for International Affairs at the Biotechnology Innovation Organization (BIO) for five years. In his role, he managed BIO’s international government affairs portfolio for Asia Pacific and worked with BIO’s members to craft international engagement strategies to promote member companies’ business interests abroad...
Greg will lead the effort to align and formalize our interactions with governments in need of our products.”
https://investor.todosmedical.com/news-events...esident-of
Back in Nov. 21
Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece
https://investor.todosmedical.com/news-events...bottles-of
1
